Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kincell Bio Secures Multi-Year Partnership with a Clinical-Stage Cell Therapy Company | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Kincell Bio Secures Multi-Year Partnership with a Clinical-Stage Cell Therapy Company

Will produce patient-specific batches of clinical-grade product at its Gainesville, Florida facility.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Kincell Bio, a cell therapy contract development and manufacturing organization (CDMO), has announced a new multi-year partnership with a clinical-stage cell therapy company. The agreement will see Kincell Bio produce patient-specific batches of clinical-grade product at its Gainesville, Florida facility.
 
This new contract adds to Kincell Bio’s growing portfolio of cell therapy projects, solidifying its position as a trusted partner in the industry. The company’s GMP-ready facility and experienced team are well-equipped to support clients’ clinical development plans and bring innovative therapies to market.
 
“We’re delighted to welcome another client to our Gainesville facility,” said Bruce Thompson, PhD., CEO of Kincell Bio. “Our facility is GMP-ready, and our team thrives on providing critical CMC development and manufacturing expertise to support our clients’ clinical development plans to help patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters